Celsius (NASDAQ:CELH) Price Target Raised to $50.00

Celsius (NASDAQ:CELH) had its price target lifted by Truist Financial from $45.00 to $50.00 in a report issued on Friday,Benzinga reports. They currently have a buy rating on the stock.

A number of other research firms also recently commented on CELH. UBS Group boosted their price objective on Celsius from $43.00 to $48.00 and gave the stock a “buy” rating in a research note on Thursday, April 17th. Piper Sandler boosted their price objective on Celsius from $44.00 to $45.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 4th. Wells Fargo & Company boosted their price objective on Celsius from $44.00 to $45.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 4th. Needham & Company LLC reissued a “buy” rating and issued a $47.00 price objective on shares of Celsius in a research note on Thursday, May 29th. Finally, LADENBURG THALM/SH SH dropped their price objective on Celsius from $62.00 to $58.00 and set a “neutral” rating on the stock in a research note on Thursday, March 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $47.22.

Celsius Stock Performance

Shares of CELH stock opened at $40.60 on Friday. Celsius has a 1 year low of $21.10 and a 1 year high of $71.00. The stock has a fifty day moving average of $36.80 and a two-hundred day moving average of $30.86. The firm has a market capitalization of $10.46 billion, a PE ratio of 92.27, a price-to-earnings-growth ratio of 2.90 and a beta of 1.43.

Celsius (NASDAQ:CELH) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.18 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.02). Celsius had a return on equity of 51.89% and a net margin of 10.70%. The business had revenue of $329.28 million for the quarter, compared to analyst estimates of $349.09 million. During the same quarter last year, the firm posted $0.27 EPS. The company’s revenue was down 7.4% compared to the same quarter last year. Equities research analysts predict that Celsius will post 0.89 earnings per share for the current fiscal year.

Insider Transactions at Celsius

In other news, Director Joyce Russell sold 4,000 shares of Celsius stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total transaction of $113,880.00. Following the transaction, the director now owns 19,106 shares in the company, valued at approximately $543,947.82. The trade was a 17.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.55% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Alliancebernstein L.P. grew its holdings in shares of Celsius by 26.3% during the first quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company’s stock valued at $642,769,000 after buying an additional 3,753,055 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Celsius by 2.2% during the fourth quarter. Vanguard Group Inc. now owns 15,813,110 shares of the company’s stock valued at $416,517,000 after buying an additional 345,837 shares in the last quarter. Alyeska Investment Group L.P. grew its holdings in shares of Celsius by 60.5% during the fourth quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company’s stock valued at $181,164,000 after buying an additional 2,591,345 shares in the last quarter. FMR LLC grew its holdings in shares of Celsius by 64.2% during the fourth quarter. FMR LLC now owns 4,055,148 shares of the company’s stock valued at $106,813,000 after buying an additional 1,585,839 shares in the last quarter. Finally, Champlain Investment Partners LLC purchased a new position in shares of Celsius during the fourth quarter valued at $85,068,000. Hedge funds and other institutional investors own 60.95% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.